In part 2 Eden and I talk about the Genomic revolution, the double helix and Francis and Crick and where insights and innovation germinate. We chat about efficacious data, the move towards precision medicine and why biotech is not involved in “nice to haves.” Biography Eden’s approach represents a progression in Investment solutions, applying options to source Income and returns through strategies not easily accessible to investors, while protecting their capital with hedges designed over his ...
view more